Hospital admissions for blood in the urine
Ward AdmiSsion of Haematuria: an Observational mUlticentre sTudy
British Urology Researchers in Surgical Training · NCT07395037
This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1050 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | British Urology Researchers in Surgical Training (other) |
| Locations | 1 site (London) |
| Trial ID | NCT07395037 on ClinicalTrials.gov |
What this trial studies
The WASHOUT project is an international, multicentre prospective observational study describing how adults admitted emergently with haematuria are managed across participating hospitals. Using the BURST collaborative model, sites collect standardized data on demographics, comorbidities, investigations, interventions and clinical outcomes with a common case report form. Primary outcome is hospital length of stay and secondary outcomes include time to diagnosis, 90-day mortality, readmission rates and healthcare resource use; analyses will use multilevel regression to explore practice variation and outcome drivers. Patients and the public were involved in the design to ensure the outcomes reflect patient priorities and real-world concerns.
Who should consider this trial
Good fit: Adults aged 16 or older who are admitted urgently to a participating urology service with haematuria (not immediately after documented catheter-related urethral trauma) and who remain in hospital for at least 24 hours.
Not a fit: Children under 16, patients with immediate catheter-related urethral trauma, and those discharged within 24 hours are excluded and are unlikely to benefit directly from this study's findings.
Why it matters
Potential benefit: If successful, this work could produce consensus guidance that shortens hospital stays, reduces complications and makes urgent haematuria care more consistent across hospitals.
How similar studies have performed: There have been single-center and regional audits that informed local practice, but few large international prospective observational efforts like this to comprehensively compare emergency haematuria management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients are included if they are over 16 years of age or older and admitted to a participating urological secondary care centre * admitted as an emergency with haematuria as the primary or secondary diagnosis under the primary or joint care of urology Exclusion Criteria: * any patients under 16 years of age * patients with catheter-related urethral trauma (defined as haemturia immediately after insertion of a urethral catheter that was documented as traumatic by the clinician, with no previous history of haemturia prior to catheter insertion) * patients that are in hospital less than 24 hours.
Where this trial is running
London
- BURST — London, United Kingdom (RECRUITING)
Study contacts
- Study coordinator: Kevin Byrnes, PhD
- Email: byrneskg@gmail.com
- Phone: 020 7679 2000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Urologic Diseases, Hematuria, Benign, Bladder Cancer, Renal Cancer, Urothelial Carcinoma, catheter, haematuria